SELECTIVE ESTROGEN RECEPTOR MODULATORS
www.freelivedoctor.com Estrogen
That Nourishes & Nurtures womanhood www.freelivedoctor.com The Feminine Hormone  Estrogen
www.freelivedoctor.com Effects of Estrogen at Various Sites in the Body Tissue Effect of Estrogen Stimulation Clinical Effect of Stimulation Clinical Effect of Absence of Stimulation Bone Increased deposits of calcium into bone Increased bone density Osteoporosis Brain Blocks the release of ovarian estrogen None Hot flashes, sleep disorders, mood changes, problems with memory? Alzheimer’s disease?? Breast Stimulates growth of breast tissue Bigger breasts,? Increased risk of breast cancer, increased sensitivity of the breast, Smaller breasts Blood Clotting Increased risk of blood clots No change in clotting Blood Fats  Increased HDL, decreased LDL, decreased Cholesterol, Decreased HDL, increased LDL, increased Cholesterol Skin Increased fat deposits in skin Softer skin Thinner skin, liver spots, dry skin Uterus Increased stimulation of uterine lining and muscle Heavier cycles, increased risk of uterine cancer No periods Vagina Increased thickening of skin, better blood supply to tissue Vaginal discharge, feelings of pelvic congestion Dryness, vaginal infections, painful sex, incontinence of urine, pelvic weakness
Molecular  Action of Estrogen www.freelivedoctor.com Adopted from George et al hsp90 – heat shock protein90
Molecular  Action of Estrogen www.freelivedoctor.com Adopted from Stanley J Birge et al AP I – activator protein CRP – co regulator protein ER – estrogen receptor ERE – estrogen response element Poly II – polymerase II TATA- adenine-thymine-rich sequence important for gene transcription
Estrogen Receptor www.freelivedoctor.com Two types have been so far identified : -    and      Molecular  Action of Estrogen Illustration by Anne Erickson
Estrogen Receptor Distribution    &     - CNS, blood vessels, bone, heart, breast, ovary, uterus, testes, prostate    -  Liver    -  Lungs, kidney, bladder, intestines www.freelivedoctor.com Adopted from George GJM Kuiper et al Based on the level of ER mRNA levels  Awaits confirmation till subtype specific monoclonal antibodies are available Molecular  Action of Estrogen
Molecular  Action of Estrogen    homodimer    homodimer    &    heterodimer Non-genomic effects www.freelivedoctor.com Adopted from George GJM Kuiper et al Alternating estrogen signaling pathways
Molecular  Action of Estrogen www.freelivedoctor.com Different response in different tissues Adopted from Lewis J. Kleinsmith Ph.D, Donna Kerrigan M.S., Jeanne Kelly
Molecular  Action of www.freelivedoctor.com Estradiol Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex®), development of a novel, "pure" antiestrogen. Cancer 2000; 89: 819.
Molecular  Action of www.freelivedoctor.com SERM (Tamoxifen) Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, "pure" antiestrogen.  Cancer  2000; 89: 819.
Molecular  Action of www.freelivedoctor.com Estrogen Receptor Down regulator  A Promising Area of Research Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, "pure" antiestrogen.  Cancer  2000; 89: 819.
Mechanism of Tissue Response - Summary www.freelivedoctor.com Oestrogen Receptor  Ligand  Complex Oestrogen  Receptor Ligand E /  SERM / PE/ERD DNA Oestrogen  Response element Gene Transcription Tissue Response Coregulatory Proteins    /   Agonistic & or Antagonistic AF 1 & 2
Selective Ostrogen Receptor Modulators www.freelivedoctor.com Estrogens Anti Estrogens SERMs SERMs- designed to act in specific ways at each of the oestrogen receptor sites in different tissues ERDR Phytoestrogens
Designer drugs  which exhibit tissue specific desirable  Estrogenic   & Antiestrogenic  actions  in different tissues “ Designer Estrogens” “ Fantasy Estrogens” Selective Ostrogen Receptor Modulators www.freelivedoctor.com They have the   potential of providing a new paradigm for maintaining the health   of women.
www.freelivedoctor.com Mer 25 (1958) Clomiphene Tamoxifen Toremifene Droloxifene Iodoxifene Raloxifene Ormeloxifene As of Today Selective Ostrogen Receptor Modulators
www.freelivedoctor.com The  Ideal  Selective Ostrogen Receptor Modulator  The perfect SERM The ideal SERM is one that prevents bone loss, has no risk of uterine  or breast cancer, a +ve effect on lipids & cardiovascular system, relieves PMS and maintains cognitive function of the brain The  Search goes on Adopted from – Rita de Cassia M  Dardes & V Craig Jordan
www.freelivedoctor.com The  Ideal  Selective Ostrogen Receptor Modulator  The perfect SERM TISSUE Endometrium Breast Vagina Bone Liver/CVS CNS Perfect  AE AE E E E E E-Estrogenic, AE-Anti Estrogenic Tamo  E AE AE E E AE Ralo  AE AE AE E E + E? Ormelo AE   AE   E   E   E   E   The  Search goes on
Tamoxifen The first true SERM. In use for breast cancer treatment since 1968, 10m patient use years. Approved for prophylactic use in1997. Beneficial effect on osteoporosis. Effect on CVS +? Lipid profile  +. www.freelivedoctor.com
Tamoxifen Has many undesirable E / AE actions. E in uterus – risk of End. Cancer. Alleged as a carcinogen. AE in vagina, CNS? Unsatisfactory safety/toxicity profile. Gave boost to the continued research for SERMs.  Under evaluation-star trial-6/99, 22000 women for 5-10 yrs. www.freelivedoctor.com
Raloxifene Originally approved (1998) for use for treatment and prevention of osteoporosis.  Subsequently (1999) approved for breast cancer prevention after  ‘MORE’  study Improved safety profile than Tamoxifen Cardiovascular effects are unequivocal & under evaluation.  www.freelivedoctor.com
Raloxifene    Risk of venous thromboembolism No effect on endometrium. AE on vagina  Effect on CNS?. No improvement in cognitive function Does not relieve PM hot flashes  Possible future use as HRT?? Is on evaluation- STAR trial www.freelivedoctor.com
ORMELOXIFENE www.freelivedoctor.com The individual elements  of the molecular structure give a tissue selectivity- different DNA transcriptions in different tissues Estrogen agonist Estrogen antagonist Chemical Name- Trans -7-methyl-2-2-dimethyl-3-phenyl-4(4-(2-pyroldinoethoxy)phenyl(-chroman hydrochloride), related to centchroman The perfect SERM
Enhanced tissue selectivity Basic amine side chain – uterine AE action Pyrolidine base – highest degree of antagonistic action Benzopyran group – agonistic action & binding affinity Very strong binding affinity to ER Quick & potent action Slow nuclear build up & prolonged retention of ER Long half life & prolonged action www.freelivedoctor.com The perfect SERM ORMELOXIFENE
ORMELOXIFENE www.freelivedoctor.com An optimally designed potent SERM with Varied Tissue Response Oestrogen Antagonist in UTERUS & BREAST Mild Oestrogenic action on Vagina, Bone mineral density, CNS and Serum Lipids No action on Hypothalamic Pituitary Ovarian function, Thyroid, Adrenal.   The perfect SERM No Progestational, Androgenic or Antiandrogenic properties
ORMELOXIFENE www.freelivedoctor.com Special benefit in perimenopausal women – Relief of PMS Currently indicated for the treatment of Dysfunctional Uterine Bleeding at ANY AGE. Not suitable  for women desiring pregnancy Approved for inclusion in National Family Welfare Program, for social marketing. The perfect SERM
ORMELOXIFENE Contraindicated in –   H/O recent liver dysfunction or clinical jaundice PCOD Cervical Dysplasia & Chronic Cervicitis Hypersensitivity to the drug Allergic conditions Nursing mothers  Chronic illness www.freelivedoctor.com The perfect SERM
ORMELOXIFENE www.freelivedoctor.com Has an excellent safety profile,very well tolerated &  practically without any undesirable side effects Easy to administer - 60mg tablet twice a week ( Sunday & Wednesday) for 12 weeks followed by one tablet of 60mg once weekly The perfect SERM
ORMELOXIFENE www.freelivedoctor.com Currently being evaluated for use in the treatment and prevention of: - Breast Cancer Osteoporosis Possible future use: - Menopause management Fibromyoma Endometriosis and Adenomyosis Contraceptive The perfect SERM
ORMELOXIFENE www.freelivedoctor.com WARNING: - Indian contribution Not introduced in the international arena Not approved by FDA Not yet fully evaluated - extensive clinical trials needed The perfect SERM
www.freelivedoctor.com “ There is no cure for birth and death save to enjoy the interval” --Santayana Selective Estrogen Receptor Modulators promise to make the interval really  enjoyable for women,  though the final words on Mode Of Action of Estrogen, Estrogen Receptors and SERMs are yet to be said.
www.freelivedoctor.com Women have reason to say SERMs have the potential of providing a new paradigm for maintaining the health of women.

Selective oestogen receptor modulators

  • 1.
  • 2.
  • 3.
    That Nourishes &Nurtures womanhood www.freelivedoctor.com The Feminine Hormone Estrogen
  • 4.
    www.freelivedoctor.com Effects ofEstrogen at Various Sites in the Body Tissue Effect of Estrogen Stimulation Clinical Effect of Stimulation Clinical Effect of Absence of Stimulation Bone Increased deposits of calcium into bone Increased bone density Osteoporosis Brain Blocks the release of ovarian estrogen None Hot flashes, sleep disorders, mood changes, problems with memory? Alzheimer’s disease?? Breast Stimulates growth of breast tissue Bigger breasts,? Increased risk of breast cancer, increased sensitivity of the breast, Smaller breasts Blood Clotting Increased risk of blood clots No change in clotting Blood Fats Increased HDL, decreased LDL, decreased Cholesterol, Decreased HDL, increased LDL, increased Cholesterol Skin Increased fat deposits in skin Softer skin Thinner skin, liver spots, dry skin Uterus Increased stimulation of uterine lining and muscle Heavier cycles, increased risk of uterine cancer No periods Vagina Increased thickening of skin, better blood supply to tissue Vaginal discharge, feelings of pelvic congestion Dryness, vaginal infections, painful sex, incontinence of urine, pelvic weakness
  • 5.
    Molecular Actionof Estrogen www.freelivedoctor.com Adopted from George et al hsp90 – heat shock protein90
  • 6.
    Molecular Actionof Estrogen www.freelivedoctor.com Adopted from Stanley J Birge et al AP I – activator protein CRP – co regulator protein ER – estrogen receptor ERE – estrogen response element Poly II – polymerase II TATA- adenine-thymine-rich sequence important for gene transcription
  • 7.
    Estrogen Receptor www.freelivedoctor.comTwo types have been so far identified : -  and  Molecular Action of Estrogen Illustration by Anne Erickson
  • 8.
    Estrogen Receptor Distribution &  - CNS, blood vessels, bone, heart, breast, ovary, uterus, testes, prostate  - Liver  - Lungs, kidney, bladder, intestines www.freelivedoctor.com Adopted from George GJM Kuiper et al Based on the level of ER mRNA levels Awaits confirmation till subtype specific monoclonal antibodies are available Molecular Action of Estrogen
  • 9.
    Molecular Actionof Estrogen  homodimer  homodimer  &  heterodimer Non-genomic effects www.freelivedoctor.com Adopted from George GJM Kuiper et al Alternating estrogen signaling pathways
  • 10.
    Molecular Actionof Estrogen www.freelivedoctor.com Different response in different tissues Adopted from Lewis J. Kleinsmith Ph.D, Donna Kerrigan M.S., Jeanne Kelly
  • 11.
    Molecular Actionof www.freelivedoctor.com Estradiol Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex®), development of a novel, "pure" antiestrogen. Cancer 2000; 89: 819.
  • 12.
    Molecular Actionof www.freelivedoctor.com SERM (Tamoxifen) Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, "pure" antiestrogen. Cancer 2000; 89: 819.
  • 13.
    Molecular Actionof www.freelivedoctor.com Estrogen Receptor Down regulator A Promising Area of Research Adapted from Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex ® ), development of a novel, "pure" antiestrogen. Cancer 2000; 89: 819.
  • 14.
    Mechanism of TissueResponse - Summary www.freelivedoctor.com Oestrogen Receptor Ligand Complex Oestrogen Receptor Ligand E / SERM / PE/ERD DNA Oestrogen Response element Gene Transcription Tissue Response Coregulatory Proteins  /  Agonistic & or Antagonistic AF 1 & 2
  • 15.
    Selective Ostrogen ReceptorModulators www.freelivedoctor.com Estrogens Anti Estrogens SERMs SERMs- designed to act in specific ways at each of the oestrogen receptor sites in different tissues ERDR Phytoestrogens
  • 16.
    Designer drugs which exhibit tissue specific desirable Estrogenic & Antiestrogenic actions in different tissues “ Designer Estrogens” “ Fantasy Estrogens” Selective Ostrogen Receptor Modulators www.freelivedoctor.com They have the potential of providing a new paradigm for maintaining the health of women.
  • 17.
    www.freelivedoctor.com Mer 25(1958) Clomiphene Tamoxifen Toremifene Droloxifene Iodoxifene Raloxifene Ormeloxifene As of Today Selective Ostrogen Receptor Modulators
  • 18.
    www.freelivedoctor.com The Ideal Selective Ostrogen Receptor Modulator The perfect SERM The ideal SERM is one that prevents bone loss, has no risk of uterine or breast cancer, a +ve effect on lipids & cardiovascular system, relieves PMS and maintains cognitive function of the brain The Search goes on Adopted from – Rita de Cassia M Dardes & V Craig Jordan
  • 19.
    www.freelivedoctor.com The Ideal Selective Ostrogen Receptor Modulator The perfect SERM TISSUE Endometrium Breast Vagina Bone Liver/CVS CNS Perfect AE AE E E E E E-Estrogenic, AE-Anti Estrogenic Tamo E AE AE E E AE Ralo AE AE AE E E + E? Ormelo AE  AE  E  E  E  E  The Search goes on
  • 20.
    Tamoxifen The firsttrue SERM. In use for breast cancer treatment since 1968, 10m patient use years. Approved for prophylactic use in1997. Beneficial effect on osteoporosis. Effect on CVS +? Lipid profile +. www.freelivedoctor.com
  • 21.
    Tamoxifen Has manyundesirable E / AE actions. E in uterus – risk of End. Cancer. Alleged as a carcinogen. AE in vagina, CNS? Unsatisfactory safety/toxicity profile. Gave boost to the continued research for SERMs. Under evaluation-star trial-6/99, 22000 women for 5-10 yrs. www.freelivedoctor.com
  • 22.
    Raloxifene Originally approved(1998) for use for treatment and prevention of osteoporosis. Subsequently (1999) approved for breast cancer prevention after ‘MORE’ study Improved safety profile than Tamoxifen Cardiovascular effects are unequivocal & under evaluation. www.freelivedoctor.com
  • 23.
    Raloxifene  Risk of venous thromboembolism No effect on endometrium. AE on vagina Effect on CNS?. No improvement in cognitive function Does not relieve PM hot flashes Possible future use as HRT?? Is on evaluation- STAR trial www.freelivedoctor.com
  • 24.
    ORMELOXIFENE www.freelivedoctor.com Theindividual elements of the molecular structure give a tissue selectivity- different DNA transcriptions in different tissues Estrogen agonist Estrogen antagonist Chemical Name- Trans -7-methyl-2-2-dimethyl-3-phenyl-4(4-(2-pyroldinoethoxy)phenyl(-chroman hydrochloride), related to centchroman The perfect SERM
  • 25.
    Enhanced tissue selectivityBasic amine side chain – uterine AE action Pyrolidine base – highest degree of antagonistic action Benzopyran group – agonistic action & binding affinity Very strong binding affinity to ER Quick & potent action Slow nuclear build up & prolonged retention of ER Long half life & prolonged action www.freelivedoctor.com The perfect SERM ORMELOXIFENE
  • 26.
    ORMELOXIFENE www.freelivedoctor.com Anoptimally designed potent SERM with Varied Tissue Response Oestrogen Antagonist in UTERUS & BREAST Mild Oestrogenic action on Vagina, Bone mineral density, CNS and Serum Lipids No action on Hypothalamic Pituitary Ovarian function, Thyroid, Adrenal. The perfect SERM No Progestational, Androgenic or Antiandrogenic properties
  • 27.
    ORMELOXIFENE www.freelivedoctor.com Specialbenefit in perimenopausal women – Relief of PMS Currently indicated for the treatment of Dysfunctional Uterine Bleeding at ANY AGE. Not suitable for women desiring pregnancy Approved for inclusion in National Family Welfare Program, for social marketing. The perfect SERM
  • 28.
    ORMELOXIFENE Contraindicated in– H/O recent liver dysfunction or clinical jaundice PCOD Cervical Dysplasia & Chronic Cervicitis Hypersensitivity to the drug Allergic conditions Nursing mothers Chronic illness www.freelivedoctor.com The perfect SERM
  • 29.
    ORMELOXIFENE www.freelivedoctor.com Hasan excellent safety profile,very well tolerated & practically without any undesirable side effects Easy to administer - 60mg tablet twice a week ( Sunday & Wednesday) for 12 weeks followed by one tablet of 60mg once weekly The perfect SERM
  • 30.
    ORMELOXIFENE www.freelivedoctor.com Currentlybeing evaluated for use in the treatment and prevention of: - Breast Cancer Osteoporosis Possible future use: - Menopause management Fibromyoma Endometriosis and Adenomyosis Contraceptive The perfect SERM
  • 31.
    ORMELOXIFENE www.freelivedoctor.com WARNING:- Indian contribution Not introduced in the international arena Not approved by FDA Not yet fully evaluated - extensive clinical trials needed The perfect SERM
  • 32.
    www.freelivedoctor.com “ Thereis no cure for birth and death save to enjoy the interval” --Santayana Selective Estrogen Receptor Modulators promise to make the interval really enjoyable for women, though the final words on Mode Of Action of Estrogen, Estrogen Receptors and SERMs are yet to be said.
  • 33.
    www.freelivedoctor.com Women havereason to say SERMs have the potential of providing a new paradigm for maintaining the health of women.

Editor's Notes

  • #12 Estradiol (E) binds with high affinity to estrogen receptor (ER) and dissociates heat shock protein 90 (HSP90) E-ER complex homodimerizes and localizes preferentially in the cell nucleus E-ER homodimer binds DNA sequence at palindromic estrogen response element (ERE) in the promotor region of estrogen-sensitive genes Activation of transcription by ER involves interaction of the transcription activation functions of ER, AF1 and AF2 with transcriptional coactivators to stimulate the activity of RNA polymerase II (RNA POL II)
  • #13 Tamoxifen (T) binds to ER with low affinity compared with estradiol (E) and dissociates heat shock protein 90 (HSP90) T-ER complex homodimerizes and translocates to the cell nucleus, and activation function (AF1) (but not AF2) is active T-ER dimer binds DNA to sequence at palindromic ERE in the promotor region of estrogen-sensitive genes Transcription of E-responsive genes(s) is attenuated because AF2 is inactive, and coactivator binding is attenuated by the T-ER complex; partial agonist activity results from AF1, which remains active in the T-ER complex
  • #14 Estradiol (E) binds with high affinity to estrogen receptor (ER) and dissociates heat shock protein 90 (HSP90) E-ER complex homodimerizes and localizes preferentially in the cell nucleus E-ER homodimer binds DNA sequence at palindromic estrogen response element (ERE) in the promotor region of estrogen-sensitive genes Activation of transcription by ER involves interaction of the transcription activation functions of ER, AF1 and AF2 with transcriptional coactivators to stimulate the activity of RNA polymerase II (RNA POL II)